CLS Q2 - Strong report that reinforces confidence in outlook

Redeye provides an update following CLS’s Q2 2025 report. We view the report as strong, providing confidence in our forecasts and the company’s objectives. Based on the results, we have made positive adjustments to our estimates, which lead to an updated fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/